- Home
- STT vs WST Comparison
STT vs WST Comparison
Compare STT & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STT
- WST
- Stock Information
- Founded
- STT 1792
- WST 1923
- Country
- STT United States
- WST United States
- Employees
- STT N/A
- WST N/A
- Industry
- STT Major Banks
- WST Medical/Dental Instruments
- Sector
- STT Finance
- WST Health Care
- Exchange
- STT Nasdaq
- WST Nasdaq
- Market Cap
- STT 25.8B
- WST 15.6B
- IPO Year
- STT N/A
- WST N/A
- Fundamental
- Price
- STT $106.11
- WST $216.71
- Analyst Decision
- STT Buy
- WST Buy
- Analyst Count
- STT 13
- WST 7
- Target Price
- STT $105.54
- WST $331.67
- AVG Volume (30 Days)
- STT 1.8M
- WST 690.0K
- Earning Date
- STT 07-15-2025
- WST 07-24-2025
- Dividend Yield
- STT 2.85%
- WST 0.38%
- EPS Growth
- STT 64.15
- WST N/A
- EPS
- STT 8.90
- WST 6.37
- Revenue
- STT $13,086,000,000.00
- WST $2,895,800,000.00
- Revenue This Year
- STT $4.72
- WST $3.38
- Revenue Next Year
- STT $3.25
- WST $5.85
- P/E Ratio
- STT $11.99
- WST $34.31
- Revenue Growth
- STT 9.48
- WST N/A
- 52 Week Low
- STT $72.65
- WST $187.43
- 52 Week High
- STT $106.83
- WST $352.33
- Technical
- Relative Strength Index (RSI)
- STT 75.99
- WST 48.20
- Support Level
- STT $99.00
- WST $215.67
- Resistance Level
- STT $98.10
- WST $223.77
- Average True Range (ATR)
- STT 1.72
- WST 4.99
- MACD
- STT 0.68
- WST -0.52
- Stochastic Oscillator
- STT 97.30
- WST 19.10
About STT State Street Corporation
State Street is a leading provider of financial services, including investment servicing, investment management, and investment research and trading. With approximately $47 trillion in assets under custody and administration and $4.7 trillion assets under management as of Dec. 31, 2024, State Street operates globally in more than 100 geographic markets and employs about 53,000 worldwide.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.